Targeting the GABA B Receptor for the Treatment of Depression and Anxiety Disorders

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/978-3-319-46044-4_12
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of GABA in the pathophysiology and treatment of anxiety disorders.

  2025cited by this paper
• Epigenetic regulation of dorsal raphe GABA(B1a) associated with isolation-induced abnormal responses to social stimulation in mice.

  2016cited by this paper
• Regulation of Neurogenesis by Neurotrophins during Adulthood: Expected and Unexpected Roles

  2016cited by this paper
• The involvement of NMDA receptor/NO/cGMP pathway in the antidepressant like effects of baclofen in mouse force swimming test

  2016cited by this paper
• Role of GABA(B) receptors in learning and memory and neurological disorders.

  2016cited by this paper
• A negative allosteric modulator modulates GABAB-receptor signalling through GB2 subunits.

  2016cited by this paper
• Decreased levels of RGS4 in the paraventricular nucleus facilitate GABAergic inhibition during the acute stress response.

  2016cited by this paper
• 60 years of advances in neuropsychopharmacology for improving brain health, renewed hope for progress.

  2015cited by this paper
• Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders.

  2015cited by this paper
• Faster, better, stronger: towards new antidepressant therapeutic strategies.

  2015cited by this paper
• Altered emotionality and neuronal excitability in mice lacking KCTD12, an auxiliary subunit of GABAB receptors associated with mood disorders

  2015cited by this paper
• The current state of the neurogenic theory of depression and anxiety.

  2015cited by this paper
• The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats.

  2015cited by this paper
• Developments in the field of antidepressants, where do we go now?

  2015cited by this paper
• A ventral view on antidepressant action: roles for adult hippocampal neurogenesis along the dorsoventral axis.

  2014cited by this paper
• GABA suppresses neurogenesis in the adult hippocampus through GABAB receptors

  2014cited by this paper
• Baclofen Add-on to Citalopram in Treatment of Posttraumatic Stress Disorder

  2014cited by this paper
• Histamine: a new immunomodulatory player in the neuron-glia crosstalk

  2014cited by this paper
• Activation but not blockade of GABAB receptors during early-life alters anxiety in adulthood in BALB/c mice.

  2014cited by this paper
• GABAB(1) receptor subunit isoforms differentially regulate stress resilience

  2014cited by this paper
• The GABAB receptor associates with regulators of G-protein signaling 4 protein in the mouse prefrontal cortex and hypothalamus

  2014cited by this paper
• Role of adult hippocampal neurogenesis in stress resilience

  2014cited by this paper
• Discovery of a Negative Allosteric Modulator of GABAB Receptors.

  2014cited by this paper
• Thirty years beyond discovery—Clinical trials in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism

  2013cited by this paper
• Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice.

  2013cited by this paper
• GABAB receptor ligands do not modify conditioned fear responses in BALB/c mice.

  2013cited by this paper
• 50 years of hurdles and hope in anxiolytic drug discovery

  2013cited by this paper
• Anticonvulsant and behavioral effects of GABA(B) receptor positive modulator CGP7930 in immature rats.

  2013cited by this paper
• Efficacy and Tolerability of Baclofen in Substance Use Disorders: A Systematic Review

  2013cited by this paper
• Regulator of G protein signaling 4 is a crucial modulator of antidepressant drug action in depression and neuropathic pain models

  2013cited by this paper
• Effects of GABA ligands injected into the nucleus accumbens shell on fear/anxiety-like and feeding behaviours in food-deprived rats.

  2012cited by this paper
• GABA(B) receptors involvement in the effects induced by nicotine on anxiety-related behaviour in mice.

  2012cited by this paper
• Blockade of the GABA(B) receptor increases neurogenesis in the ventral but not dorsal adult hippocampus: relevance to antidepressant action.

  2012cited by this paper
• GABAB receptors-associated proteins: potential drug targets in neurological disorders?

  2012cited by this paper
• Regulation of neuronal GABAB receptor functions by subunit composition

  2012cited by this paper
• Adult hippocampal neurogenesis buffers stress responses and depressive behavior

  2011cited by this paper
• Cost of disorders of the brain in Europe 2010.

  2011cited by this paper
• The age of anxiety: role of animal models of anxiolytic action in drug discovery

  2011cited by this paper
• Genome-wide association study of bipolar I disorder in the Han Chinese population

  2011cited by this paper
• An historical perspective on GABAergic drugs.

  2011cited by this paper
• Discovery of a novel potent GABA(B) receptor agonist.

  2011cited by this paper
• The size and burden of mental disorders and other disorders of the brain in Europe 2010.

  2011cited by this paper
• Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain

  2011cited by this paper
• The GABAB receptor as a target for antidepressant drug action

  2011cited by this paper
• Neurotrophic Factors and Antidepressant Action: Recent Advances

  2010cited by this paper
• GABAB receptors: physiological functions and mechanisms of diversity.

  2010cited by this paper
• Effects of imipramine or GABA(B) receptor ligands on the immobility, swimming and climbing in the forced swim test in rats following discontinuation of cocaine self-administration.

  2010cited by this paper
• Acute stress responsive RGS proteins in the mouse brain

  2010cited by this paper
• Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression.

  2010cited by this paper
• Chemistry and pharmacology of GABAB receptor ligands.

  2010cited by this paper
• GABAB receptors and depression. Current status.

  2010cited by this paper
• Pharmacological treatment of generalized anxiety disorder.

  2010cited by this paper
• Succinic semialdehyde dehydrogenase deficiency: Lessons from mice and men

  2009cited by this paper
• Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis

  2009cited by this paper
• Severity of atypical absence phenotype in GABAB transgenic mice is subunit specific.

  2009cited by this paper
• Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression

  2009cited by this paper
• Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression.

  2009cited by this paper
• What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression.

  2009cited by this paper
• Drug development for Alzheimer's disease: where are we now and where are we headed?

  2009cited by this paper
• Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-Immunoreactive neuropil.

  2009cited by this paper
• Changes in the properties of allosteric and orthosteric GABAB receptor ligands after a continuous, desensitizing agonist pretreatment.

  2009cited by this paper
• Anxiety disorders: a comprehensive review of pharmacotherapies.

  2008cited by this paper
• Characterization of (R,S)‐5,7‐di‐tert‐butyl‐3‐hydroxy‐3‐trifluoromethyl‐3H‐benzofuran‐2‐one as a positive allosteric modulator of GABAB receptors

  2008cited by this paper
• TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment.

  2008cited by this paper
• Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABAB receptor desensitization.

  2008cited by this paper
• Evaluation of the anxiolytic-like profile of the GABAB receptor positive modulator CGP7930 in rodents.

  2008cited by this paper
• Specific roles of GABA(B(1)) receptor isoforms in cognition.

  2007cited by this paper
• Reduced 5-HT1A- and GABAB receptor function in dorsal raphé neurons upon chronic fluoxetine treatment of socially stressed rats.

  2007cited by this paper
• Effects of GABAB receptor ligands in animal tests of depression and anxiety.

  2007cited by this paper
• Behavioral evaluation of mice deficient in GABAB(1) receptor isoforms in tests of unconditioned anxiety

  2007cited by this paper
• Transgenic mice over-expressing GABA(B)R1a receptors acquire an atypical absence epilepsy-like phenotype.

  2007cited by this paper
• Baclofen blocks expression and sensitization of anxiety-like behavior in an animal model of repeated stress and ethanol withdrawal.

  2007cited by this paper
• The amygdala regulates the antianxiety sensitization effect of flumazenil during repeated chronic ethanol or repeated stress.

  2007cited by this paper
• GABAergic Neurons Immunoreactive for Calcium Binding Proteins are Reduced in the Prefrontal Cortex in Major Depression

  2007cited by this paper
• The STAR*D project results: A comprehensive review of findings

  2007cited by this paper
• GABAA and GABAB agonist microinjections into medial accumbens shell increase feeding and induce anxiolysis in an animal model of anxiety.

  2007cited by this paper
• Syntheses and optimization of new GS39783 analogues as positive allosteric modulators of GABA B receptors.

  2007cited by this paper
• Is the GABAB heterodimer a good drug target?

  2007cited by this paper
• Effects of GABAB receptor ligands in rodent tests of anxiety-like behavior.

  2007cited by this paper
• Chemistry of GABAB Modulators

  2007cited by this paper
• GABAB receptor: a site of therapeutic benefit.

  2006cited by this paper
• Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress

  2006cited by this paper
• GABA(B) receptor function and subunit expression in the rat spinal cord as indicators of stress and the antinociceptive response to antidepressants.

  2006cited by this paper
• Generalization of amygdala LTP and conditioned fear in the absence of presynaptic inhibition

  2006cited by this paper
• Clinical potential of GABAB receptor modulators.

  2006cited by this paper
• Antidepressant-like effects of baclofen and LY367385 in the forced swim test in rats.

  2006cited by this paper
• GABAB(1) Receptor Isoforms Differentially Mediate the Acquisition and Extinction of Aversive Taste Memories

  2006cited by this paper
• Differential compartmentalization and distinct functions of GABAB receptor variants.

  2006cited by this paper
• Antidepressant‐like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents

  2006cited by this paper
• Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

  2006cited by this paper
• CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.

  2006cited by this paper
• Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor.

  2005cited by this paper
• Cost of disorders of the brain in Europe

  2005cited by this paper
• Brain-Derived Neurotrophic Factor and Antidepressant Drugs Have Different But Coordinated Effects on Neuronal Turnover, Proliferation, and Survival in the Adult Dentate Gyrus

  2005cited by this paper
• The GABAB Receptor-Positive Modulator GS39783 and the GABAB Receptor Agonist Baclofen Attenuate the Reward-Facilitating Effects of Cocaine: Intracranial Self-Stimulation Studies in the Rat

  2005cited by this paper
• GABAB Receptor Antagonist-Mediated Antidepressant-Like Behavior Is Serotonin-Dependent

  2005cited by this paper
• Altered anxiety and depression-related behaviour in mice lacking GABAB(2) receptor subunits

  2005cited by this paper
• Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS

  2005cited by this paper
• Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression.

  2005cited by this paper
• Structural Analysis of the Complement Control Protein (CCP) Modules of GABAB Receptor 1a

  2004cited by this paper

• A Review of the Characteristics of Clinical Trials and Potential Medications for Alcohol Dependence: Data Analysis from ClinicalTrials.gov

  2023cites this paper
• COR758, a negative allosteric modulator of GABAB receptors.

  2021cites this paper
• The influence of anxiety symptoms on clinical outcomes during baclofen treatment of alcohol use disorder: A systematic review and meta-analysis.

  2021cites this paper
• Genetic inactivation of the sigma-1 chaperone protein results in decreased expression of the R2 subunit of the GABA-B receptor and increased susceptibility to seizures.

  2020cites this paper
• Baclofen in the Treatment of Alcohol Use Disorder

  2019cites this paper
• Potential of GABAB Receptor Positive Allosteric Modulators in the Treatment of Alcohol Use Disorder

  2019cites this paper
• Social Environment and Epigenetics.

  2019cites this paper
• Baclofen in the Treatment of Patients With Alcohol Use Disorder and Other Mental Health Disorders

  2018cites this paper
• Inhibition in the amygdala anxiety circuitry

  2018cites this paper
• Suppressing effect of COR659 on alcohol, sucrose, and chocolate self-administration in rats: involvement of the GABAB and cannabinoid CB1 receptors

  2017cites this paper